Wird geladen...
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone
Background: A systemic immune-inflammation index (SII) based on neutrophil (N), lymphocyte (L), and platelet (P) counts has shown a prognostic impact in several solid tumors. The aim of this study is to evaluate the prognostic role of SII in metastatic castration-resistant prostate cancer (mCRPC) pa...
Gespeichert in:
Veröffentlicht in: | Front Pharmacol |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Frontiers Media S.A.
2016
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5062111/ https://ncbi.nlm.nih.gov/pubmed/27790145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00376 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|